Search alternatives:
significant changes » significant challenge (Expand Search)
changes decrease » largest decrease (Expand Search), change increases (Expand Search)
larger decrease » marked decrease (Expand Search)
lower decrease » linear decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
Showing 41 - 60 results of 9,407 for search '(( significant changes decrease ) OR ( significantly ((lower decrease) OR (larger decrease)) ))', query time: 0.35s Refine Results
  1. 41
    Correlation between protein abundances and R<sub>5-20</sub> z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (<i>TF, Serotransferrin; F2, Prothrombin; CFI, Complement factor I; HPX, Hemopexin; C4A/C4B, Complement C4b; GC, Vitamin D-binding protein; SERPINA7, Thyroxine-binding globulin; CFB, Complement factor B; APOH, Beta-2-glycoprotein 1; NTM, Neurotrimin</i>).

    Correlation between protein abundances and R<sub>5-20</sub> z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (... by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 42
    General characteristics and clinical data of the subjects included in the study.

    General characteristics and clinical data of the subjects included in the study. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 43
    Distribution of average relative amounts of lipid classes.

    Distribution of average relative amounts of lipid classes. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 44
    Flow chart on the inclusion and drop out of patients.

    Flow chart on the inclusion and drop out of patients. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 45
    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls.

    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 46
    Symptoms reported by COVID-19 cases at baseline and at follow-up.

    Symptoms reported by COVID-19 cases at baseline and at follow-up. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 47
    Transepithelial resistance of NHBE decreases significantly after PAA exposure.

    Transepithelial resistance of NHBE decreases significantly after PAA exposure. by Ellie S. Burns (21246537)

    Published 2025
    Save to List
    Saved in:
  8. 48
    The global disease burden of <i><i>Klebsiella pneumoniae</i></i> associated LRI for both sexes in 204 countries and territories. (a) The number of deaths in 2021; (b) The EAPC of deaths from 1990 to 2019; (c) The change in death cases between 1990 and 2019. EAPC estimated annual percentage change, LRI lower respiratory infections.

    The global disease burden of <i><i>Klebsiella pneumoniae</i></i> associated LRI for both sexes in 204 countries and territories. (a) The number of deaths in 2021; (b) The EAPC of d... by Juanjuan Li (399633)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 49
    Correlation between treatment-induced changes in lumbar motor control and N150 amplitude.

    Correlation between treatment-induced changes in lumbar motor control and N150 amplitude. by Soheila Qanbari (20455173)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 50
    Linear relationships (Spearman’s r (p-value)) the treatment-induced changes in clinical and neurophysiological data.

    Linear relationships (Spearman’s r (p-value)) the treatment-induced changes in clinical and neurophysiological data. by Soheila Qanbari (20455173)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 51
    Changes in health-related quality of life indexes before and after disease onset.

    Changes in health-related quality of life indexes before and after disease onset. by Ji Woong Chang (1829314)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 52
    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment.

    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 53
    Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment.

    Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 54
    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment.

    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 55
    The global disease burden of <i><i>Klebsiella pneumoniae</i></i> associated LRI for both sexes in 204 countries and territories. (a) The number of DALYs in 2021; (b) The EAPC of DALYs from 1990 to 2019; (c) The change in DALYs cases between 1990 and 2019. DALYs disability-adjusted life years, EAPC estimated annual percentage change, LRI lower respiratory infections.

    The global disease burden of <i><i>Klebsiella pneumoniae</i></i> associated LRI for both sexes in 204 countries and territories. (a) The number of DALYs in 2021; (b) The EAPC of DA... by Juanjuan Li (399633)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 56
    Visual examples of the change in maximum height measure.

    Visual examples of the change in maximum height measure. by Teagan McMahon (20108036)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 57
    Restricted cubic spline plots showing the association between changes in PAL and risk of CVD.

    Restricted cubic spline plots showing the association between changes in PAL and risk of CVD. by Haiwei Li (282229)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 58
    The proportional change in maximum height for the five study groups.

    The proportional change in maximum height for the five study groups. by Teagan McMahon (20108036)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 59
    Changes of physical and biochemical indicators from baseline and difference between DKD and non-DKD patients.

    Changes of physical and biochemical indicators from baseline and difference between DKD and non-DKD patients. by Ningning Wang (560944)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 60
    Larger example of stimuli with cue relevant for Task 3.

    Larger example of stimuli with cue relevant for Task 3. by Marcel F. Hinss (14675457)

    Published 2024
    Save to List
    Saved in:

Search Tools: